课题基金 / 基金详情

The NF2 gene: elucidation of tumor suppressor function

The NF2 gene: elucidation of tumor suppressor function
NF2基因:阐明肿瘤抑制功能
批准号:
6648978
负责人:
JOSEPH KISSIL
金额:
$4.81万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2005-04-30

项目摘要

项目成果

JOSEPH KISSIL的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):2型神经纤维瘤病(NF2)是一种以第八脑神经雪旺细胞瘤为特征的遗传性疾病。NF2基因编码一种与ERM蛋白moesin、ezrin和radixin高度相关的蛋白质,因此被称为merlin。ERM蛋白被认为是细胞膜-细胞骨架连接物。Merlin至少部分受到Rac/cdc42依赖性磷酸化的调节。最近的数据表明,merlin可能是Rac/cdc42信号通路的负调控因子。该计划的重点是研究merlin的肿瘤抑制特性,以及通过merlin连接细胞外信号与细胞骨架组织和/或细胞增殖状态的信号通路。这项工作涉及两种结合的方法:1)了解merlin如何与Rac/cdc42信号通路相互作用和调节。2) merlin的结构/功能研究,包括将该蛋白的异构体和突变形式引入nf2缺陷细胞。具体地说,影响梅林磷酸化的突变将被检查。拟议的项目将阐明merlin的生长抑制作用以及可能与Rac/cdc42通路的串扰。这将有助于我们更好地了解正常细胞中的merlin功能,以及它在肿瘤发展过程中丧失的后果。这些信息将直接有助于寻找有效的治疗方法。
英文摘要
DESCRIPTION (provided by applicant): Neurofibromatosis type 2 (NF2) is an inherited disorder characterized by development of Schwann cell tumors of the eighth cranial nerve. The NF2 gene codes for a protein highly related to the ERM proteins moesin, ezrin and radixin and was thus termed merlin. The ERM proteins are thought to function as cell membrane-cytoskeleton linkers. Merlin is regulated, at least in part, by Rac/cdc42-dependent phosphorylation. Recent data implicates merlin as a possible negative regulator of the Rac/cdc42 signaling pathway. The proposed project focuses on the study of the tumor suppressive properties of merlin and the signaling pathways connecting extracellular signals to cytoskeletal organization and/or the proliferative state of the cell, via merlin. The work involves two combined approaches: 1) Understanding how merlin might interact with and regulate, the Rac/cdc42 signaling pathway. 2) Structure/function studies of merlin involving introduction of isoforms and mutated forms of the protein into Nf2-deficient cells. Specifically, mutations effecting merlin phosphorylation will be examined. The proposed project should shed light on the growth suppressive effects of merlin and possible cross-talk with the Rac/cdc42 pathway. This should lead to a better understanding of merlin function in normal cells and the consequences of its loss in tumor development. Such information will directly assist in the search for effective therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
Employing functionalized fragment libraries to identify therapeutic agents for neurofibromatosis type 2
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
海外基金